ABBV vs CVX: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Chevron Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Chevron Corporation · Energy
$205.52
+35.9% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
CVX has more upside to fair value
(+35.9%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
CVX |
| Current Price |
$261.70 |
$205.52 |
| Fair Value Estimate |
$259.04 |
$279.29 |
| Upside to Fair Value |
-1.0%
|
+35.9%
|
| Market Cap |
$462.4B |
$409.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
7.8x
|
| Price / Sales |
7.2x
|
2.0x
|
| Price / FCF |
23.6x
|
15.0x
|
| Revenue Growth YoY |
+10.2%
|
+51.4%
|
| Gross Margin |
71.5%
|
31.0%
|
| Operating Margin |
29.3%
|
15.8%
|
| Return on Equity |
-136.5%
|
11.0%
|
| Dividend Yield |
2.61% |
3.43% |
| FCF Yield |
4.25%
|
6.67%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Chevron is a global integrated oil and gas major organized into Upstream and Downstream segments, spanning crude oil and natural gas exploration, LNG processing and transport, refining, petrochemicals, and lubricants, with 43,039 full-time employees and a market capitalization of $409.31 billion at a current price of $205.52. The business quality is high: it generates $13.71 of free cash flow per…
Accumulation Zones
| Metric |
ABBV |
CVX |
| Zone Low |
$194.28 |
$209.47 |
| Zone High |
$220.18 |
$237.40 |
| In Buy Zone? |
No
|
Yes
|